MedTrace Logo

Predictive Models of Hepatic Decompensation and Survival Outcomes in Pediatric Patients With Cirrhosis

NCT05181332 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 400

Last updated 2022-01-20

No results posted yet for this study

Summary

The aim of this study was to developed and validated models to predict hepatic decompensation and survivals in pediatric patients with cirrhosis and compared these models with currently available models.

Conditions

  • Cirrhosis
  • Biliary Atresia
  • Choledochal Cyst
  • Primary Sclerosing Cholangitis
  • HBV
  • HCV
  • Autoimmune Hepatitis

Interventions

OTHER

Prediction model

Clinical models were developed and validated to predict liver-related complications and survival outcomes in pediatric patients with biopsy-proven with cirrhosis.

Sponsors & Collaborators

  • West China Hospital

    lead OTHER

Eligibility

Min Age
0 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-01-01
Primary Completion
2024-12-31
Completion
2024-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05181332 on ClinicalTrials.gov